1例<italic style="font-style: italic">SMARCA</italic>4胚系变异卵巢高钙血症型小细胞癌的综合治疗和遗传咨询

郜意; 康茗贻; 王辉; 胥婧; 石月; 陶祥; 马凤华; 谭灏文; 康玉; 徐丛剑

doi:10.19401/j.cnki.1007-3639.2022.11.010

您当前的位置：

首页 >

文章列表页 >

1例SMARCA4胚系变异卵巢高钙血症型小细胞癌的综合治疗和遗传咨询

个案报道 | 更新时间：2025-12-31

- 1例SMARCA4胚系变异卵巢高钙血症型小细胞癌的综合治疗和遗传咨询
- Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type
- 中国癌症杂志 2022年32卷第11期页码：1115-1120
- 作者机构：
  
  1. 复旦大学附属妇产科医院妇科，上海 200011
  2. 上海市女性生殖内分泌相关疾病重点实验室，上海 200011
  3. 复旦大学附属妇产科医院护理部，上海 200011
  4. 复旦大学附属妇产科医院病理科，上海 200011
  5. 复旦大学附属妇产科医院放射科，上海 200011
  6. 江西合因教育科技有限公司，江西赣州 342604
  7. 复旦大学上海医学院妇产科学系，上海，200032
- 作者简介：
  
  [ "郜意（ORCID: 0000-0003-3634-8087），博士在读。" ]
  康玉（ORCID: 0000-0003-1197-4727），博士，主任医师、副教授。
- 基金信息：
  
  上海申康医院发展中心临床科技创新项目(SHDC12020108);上海市老龄化和妇儿健康研究专项(2020YJZX0202)
- DOI：10.19401/j.cnki.1007-3639.2022.11.010
  中图分类号： R737.31
- 收稿：2022-06-08，
  
  修回：2022-11-15，
  
  纸质出版：2022-11-30
- 稿件说明：
移动端阅览
郜意, 康茗贻, 王辉, 等. 1例SMARCA4胚系变异卵巢高钙血症型小细胞癌的综合治疗和遗传咨询[J]. 中国癌症杂志, 2022,32(11):1115-1120.

Yi GAO, Mingyi KANG, Hui WANG, et al. Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type[J]. China Oncology, 2022, 32(11): 1115-1120.
郜意, 康茗贻, 王辉, 等. 1例SMARCA4胚系变异卵巢高钙血症型小细胞癌的综合治疗和遗传咨询[J]. 中国癌症杂志, 2022,32(11):1115-1120. DOI： 10.19401/j.cnki.1007-3639.2022.11.010.

Yi GAO, Mingyi KANG, Hui WANG, et al. Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type[J]. China Oncology, 2022, 32(11): 1115-1120. DOI： 10.19401/j.cnki.1007-3639.2022.11.010.

摘要

Abstract

关键词

Keywords

references

PODWIKA S E , JENKINS T M , KHOKHAR J K , et al. Optimal age for genetic cancer predisposition testing in hereditary SMARCA 4 ovarian cancer families: how young is too young? [J ] . Gynecol Oncol Rep , 2020 , 32 : 100569 .

LEE E K , ESSELEN K M , KOLIN D L , et al. Combined CDK4/6 and PD-1 inhibition in refractory SMARCA 4-deficient small-cell carcinoma of the ovary, hypercalcemic type [J ] . JCO Precis Oncol , 2020 , 4 : 736 - 742 .

CONNOR Y D , MIAO D A , LIN D I , et al. Germline mutations of SMARCA 4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA 4-deficient undifferentiated uterine sarcoma: clinical features of a single family and comparison of large cohorts [J ] . Gynecol Oncol , 2020 , 157 ( 1 ): 106 - 114 . DOI: 10.1016/j.ygyno.2019.10.031 http://doi.org/10.1016/j.ygyno.2019.10.031 https://linkinghub.elsevier.com/retrieve/pii/S009082581931618X https://linkinghub.elsevier.com/retrieve/pii/S009082581931618X

HUGHES I A , HOUK C , AHMED S F , et al. Consensus statement on management of intersex disorders [J ] . J Pediatr Urol , 2006 , 2 ( 3 ): 148 - 162 . DOI: 10.1016/j.jpurol.2006.03.004 http://doi.org/10.1016/j.jpurol.2006.03.004

FOULKES W D , KAMIHARA J , EVANS D G R , et al. Cancer surveillance in gorlin syndrome and rhabdoid tumor predisposition syndrome [J ] . Clin Cancer Res , 2017 , 23 ( 12 ): e62 -e67. DOI: 10.1158/1078-0432.CCR-17-0595 http://doi.org/10.1158/1078-0432.CCR-17-0595 https://aacrjournals.org/clincancerres/article/23/12/e62/80076/Cancer-Surveillance-in-Gorlin-Syndrome-and https://aacrjournals.org/clincancerres/article/23/12/e62/80076/Cancer-Surveillance-in-Gorlin-Syndrome-and

PEJOVIC T , MCCLUGGAGE W G , KRIEG A J , et al. The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type [J ] . Gynecol Oncol Rep , 2019 , 28 : 47 - 49 .

YOUNG R H , OLIVA E , SCULLY R E . Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases [J ] . Am J Surg Pathol , 1994 , 18 ( 11 ): 1102 - 1116 .

CALLEGARO-FILHO D , GERSHENSON D M , NICK A M , et al. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): a review of 47 cases [J ] . Gynecol Oncol , 2016 , 140 ( 1 ): 53 - 57 . DOI: 10.1016/j.ygyno.2015.11.004 http://doi.org/10.1016/j.ygyno.2015.11.004 https://linkinghub.elsevier.com/retrieve/pii/S0090825815301761 https://linkinghub.elsevier.com/retrieve/pii/S0090825815301761

WITKOWSKI L , GOUDIE C , RAMOS P , et al. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type [J ] . Gynecol Oncol , 2016 , 141 ( 3 ): 454 - 460 . DOI: S0090-8258(16)30071-3 http://doi.org/S0090-8258(16)30071-3

JAMY O , YAGHMOUR G , HARE F , et al. Population-based analysis of the clinical features of primary small cell carcinoma of the ovary [J ] . Anticancer Res , 2015 , 35 ( 5 ): 3091 - 3095 .

ESTEL R , HACKETHAL A , KALDER M , et al. Small cell carcinoma of the ovary of the hypercalcaemic type: an analysis of clinical and prognostic aspects of a rare disease on the basis of cases published in the literature [J ] . Arch Gynecol Obstet , 2011 , 284 ( 5 ): 1277 - 1282 . DO I: 10.1007/s00404-011-1846-5 http://doi.org/10.1007/s00404-011-1846-5

RAY-COQUARD I , MORICE P , LORUSSO D , et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J ] . Ann Oncol , 2018 , 29 ( Suppl 4 ): iv1 -iv18. DOI: 10.1093/annonc/mdy001 http://doi.org/10.1093/annonc/mdy001 https://linkinghub.elsevier.com/retrieve/pii/S0923753419316898 https://linkinghub.elsevier.com/retrieve/pii/S0923753419316898

WANG Y M , CHEN S Y , KARNEZIS A N , et al. The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type [J ] . J Pathol , 2017 , 242 ( 3 ): 371 - 383 . DOI: 10.1002/path.4912 http://doi.org/10.1002/path.4912 https://onlinelibrary.wiley.com/doi/10.1002/path.4912 https://onlinelibrary.wiley.com/doi/10.1002/path.4912

WANG Y M , CHEN S Y , COLBORNE S , et al. Histone deacetylase inhibitors synergize with catalytic inhibitors of EZH2 to exhibit antitumor activity in small cell carcinoma of the ovary, hypercalcemic type [J ] . Mol Cancer Ther , 2018 , 17 ( 12 ): 2767 - 2779 . DOI: 10.1158/1535-7163.MCT-18-0348 http://doi.org/10.1158/1535-7163.MCT-18-0348

SOLDI R , GHOSH HALDER T , WESTON A , et al. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer [J ] . PLoS One , 2020 , 15 ( 7 ): e0235705 . DOI: 10.1371/journal.pone.0235705 http://doi.org/10.1371/journal.pone.0235705 https://dx.plos.org/10.1371/journal.pone.0235705 https://dx.plos.org/10.1371/journal.pone.0235705

LANG J D , HENDRICKS W P D , ORLANDO K A , et al. Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multikinase inhibition [J ] . Clin Cancer Res , 2018 , 24 ( 8 ): 1932 - 1943 . DOI: 10.1158/1078-0432.CCR-17-1928 http://doi.org/10.1158/1078-0432.CCR-17-1928

XUE Y B , MEEHAN B , MACDONALD E , et al. CDK4/6 inhibitors target SMARCA 4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary [J ] . Nat Commun , 2019 , 10 ( 1 ): 558 . DOI: 10.1038/s41467-018-06958-9 http://doi.org/10.1038/s41467-018-06958-9 https://doi.org/10.1038/s41467-018-06958-9 https://doi.org/10.1038/s41467-018-06958-9

JELINIC P , RICCA J , VAN OUDENHOVE E , et al. Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade [J ] . J Natl Cancer Inst , 2018 , 110 ( 7 ): 787 - 790 . DOI: 10.1093/jnci/djx277 http://doi.org/10.1093/jnci/djx277

TISCHKOWITZ M , HUANG S D , BANERJEE S , et al. Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines [J ] . Clin Cancer Res , 2020 , 26 ( 15 ): 3908 - 3917 . DOI: 10.1158/1078-0432.CCR-19-3797 http://doi.org/10.1158/1078-0432.CCR-19-3797

ZHANG F F , WANG W J , LONG Y , et al. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response [J ] . Cancer Commun (Lond) , 2018 , 38 ( 1 ): 60 .

BERCHUCK A , WITKOWSKI L , HASSELBLATT M , et al. Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type [J ] . Gynecol Oncol Rep , 2015 , 12 : 20 - 22 .

浏览量

2224

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

妇科肿瘤遗传咨询专家共识（2023年版）

单细胞RNA测序技术揭示卵巢高钙血症型小细胞癌复发病灶的细胞分子特征

1例SMARCA4胚系变异卵巢高钙血症型小细胞癌的综合治疗和遗传咨询

Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type

DOI：10.19401/j.cnki.1007-3639.2022.11.010

摘要

Abstract

关键词

Keywords

references